Anti-caspase-8 autoantibody response in silicosis patients is associated with HLA-DRB1, DQB1 and DPB1 alleles

Journal of Occupational Health

Volumn 47, Issue 1, 2005, Pages 61-67

  Ueki, Ayako ^a   Isozaki, Yumika ^b   Kusaka, Masayasu ^c  

^a KAWASAKI UNIVERSITY OF MEDICAL WELFARE   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

^c Kusaka Hospital   (Japan)

Author keywords

Autoantibodies; Caspase 8; HLA class II alleles; Silicosis

Indexed keywords

ASPARTIC ACID; AUTOANTIBODY; CASPASE 8; GLUTAMIC ACID; HLA ANTIGEN CLASS 2; HLA DP ANTIGEN; HLA DPB1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; LYSINE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY SCREENING; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; GENE FREQUENCY; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PEMPHIGUS VULGARIS; RHEUMATOID ARTHRITIS; RISK FACTOR; SILICOSIS;

ALLELES; AUTOANTIBODIES; BASE SEQUENCE; CASPASE 8; CASPASES; DNA PRIMERS; HLA-DP ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SILICOSIS;

EID: 14544301907     PISSN: 13419145     EISSN: None     Source Type: Journal    
DOI: 10.1539/joh.47.61     Document Type: Article

References (28)

1. A Ueki, Y Isozaki, A Tomokuni, T Hatayama, H Ueki, M Kusaka, M Shiwa, H Arikuni, T Takeshita and K Morimoto: Intramolecular epitope spreading among anti-caspase-8 autoantibodies in patients with silicosis, systemic sclerosis and systemic lupus erythematosus, as well as in healthy individuals. Clin Exp Immunol 129, 556-561 (2002)
2. A Ueki, M Yamaguchi, H Ueki, Y Watanabe, G Ohsawa, K Kinugawa, Y Kawakami and F Hyodoh: Polyclonal human T-cell activation by silicate in vitro. Immunology 82, 332-335 (1994)
3. A Ueki, Y Isozaki, A Tomokuni, H Ueki, M Kusaka, S Tanaka, T Otsuki, H Sakaguchi and F Hyodoh: Different distribution of HLA Class II alleles in anti-topoisomerase I autoantibody responders between silicosis and systemic sclerosis patients, with a common distinct amino acid sequence in the HLA-DQB1 domain. Immunobiology 204, 390-397 (2001)
4. A Tomokuni, T Aikoh, T Matsuki, Y Isozaki, T Otsuki, S Kita, H Ueki, M Kusaka, T Kishimoto and A Ueki: Elevated soluble fas/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumors. Clin Exp Immunol 110, 303-309 (1997)
5. JP Medema, C Scaffidi, FC Kischkel, A Shevchenko, M Mann, PH Krammer and ME Peter: FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 81, 935-945 (1997)
6. GH Fisher, FJ Rosenberg, SE Straus, S Gerwinski, T martin, C Berljung, A Gruneiro, SJ Chou, EH Man and S Pappatheodorou: Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935-945 (1995)
7. F Rieuz-Iaucat, F Le Deist, C Hivroz, IA Roberts, KM Debatin, A Fisher and JP de Villartay: Mutation's in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268, 1347-1349 (1995)
8. KM Gillespie, EAM Gale and PJ Bingley: High familial risk and genetic susceptibility in early onset childhood diabetes. Diabetes 51, 210-224 (2002)
9. A Perdriger, P Guggenbuhl, G Chales, P Le Dantec, J Yaouanq, B Genetet and Y Pawlotsky: The role of HLA-DR-DR and HLA-DR-DP interactions in genetic susceptibility to rheumatoid arthritis. Human Immunol 46, 42-48 (1996)
10. C Seidl, U Koch, G Bruennler, T Buhleier, R Frank, B Moller, E Markert and G Koller-Wagner: HLA-DR/DQ/DP interactions in rheumatoid arthritis. Eur J Immunogen 24, 356-376 (1997)
11. JD Reveille and FC Amett: The immunogenetics of Sjogren's syndrome. Rheum Dis Clin North Am 18, 539-550 (1992)
12. HI Kang, HM Fei, I Saito I, S Sawada, SL Chen, D Yi, E Chan, C Peebles, TL Bugawan and HA Erlich: Comparison of HLA class II genes in Caucasoid, Chinese, and Japanese patients with primary Sjogren's syndrome. J Immunol 150, 3615-3623 (1993)
13. Akaza T. Frequency of the HLA allele in Japanese. In: Nakajima I, Takahashi T, Yoshikai Y, eds. Simple Immunology. Tokyo: Nankado, 2001: 211 (in Japanese).
14. M Ota, T Seki and H Fukushima: HLA-DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers. Tissue Antigens 39, 187-202 (1992)
15. Cohen D, Simons M, Lalouel M. Nomenclature for HLA-RFLP. In: Dupont B, ed. Immunobiology of HLA. vol 1. Histocompatibility Testing 1987. New York: Springer-Verlag, 1989: 66-71.
16. N Nomura, M Ota, K Tsuji and H Inoko: HLA-DQB1 genotyping by mdified PCR-RFLP method combined with allele-specific primer. Tissue Antigens 38, 53-59 (1991)
17. M Ota, T Seki, N Nomura, K Sugimura, N Mizuki, H Fukushima, K Tsuji and H Inoko: Modified PCR-RFLP method for HLA-DPB1 and DQA1 genotyping. Tissue Antigens 38, 60-71 (1991)
18. MA Gonzalez-Gay, AH Hajeer and C Garcia-Porrua: Patients chosen for treatment with cyclosporine bacause of severe rheumatoid arthritis are more likely to carry HLA-DRB1 shared epitope alleles, and have earlier disease onset. J Rheumatol 29, 271-275 (2002)
19. DL Mattey, PT Dawes and S Clarke: Relationship among the HLA-DRB1 shared epirope, smoking, and rheumatoid factor production in rheumatoid arthritis. Arthritis & Rheum 47, 403-407 (2002)
20. J Setterfield, J Theron and RW Vaughan: Mucous membrane pemphigoid: HLADQB1:0301 is associated with all clinical sites of involvement and may be linked to antibasement membrane IgG production. Brit J Derm 145, 406-414 (2002)
21. Mathis D, Goodnow CC, Ravetch J. Autoimmunity and Transplantation. In: Janeway CA, Travers P, Walport M, Shlomchik MJ, eds. Immunobiology 5th. New York: Garland Publishing, 2001: 501-551.
22. HP Rihs, K Conrad and J Mehlhorn: Molecular analysis of HLA-DPB1 alleles in idiopathic systemic sclerosis patients and uranium miners with systemic sclerosis. Int Arch Allergy Immunol 109, 216-222 (1996)
23. UF Haustein, V Ziegler, K Herrmann, J Mehlhorn and C Schmidt: Silica-induced scleroderma. J Am Acad dermatol 22, 444-448 (1990)
24. J Snachez-Roman, I Wichmann, J Salaberri, JM Varela and A Nunez-Roldan: Multiple clinical and biological autoimmune manifestations in 50 workers after occupational exposure to silica. Ann Rheum Dis 52, 534-538 (1993)
25. T Otsuki, H Sakaguchi, A Tomokuni, T Aikoh, T Matsuki, Y Kawakami, M Kusaka, H Ueki, S Kita and A Ueki: Soluble Fas mRNA is dominantly expressed in cases with silicosis. Immunology 94, 258-262 (1998)
26. JP Medema, C Scaffidi, FC Kischkel, A Shevchenko, M Mann, PH Krammer and ME Peter: FLICE is activated by association with the CD95 death-inducing signaling complex(DISC). EMBO J 16, 2794-804 (1997)
27. GH Fisher, FJ Rosenberg, SE Straus, S Gerwinski, T Martin, C Berglung, A Gruneiro, SJ Chou, EH Man and S Pappatheodorou: Dominant interfiring Fas gene Mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935-945 (1995)
28. F Rieux-Laucat, F Le Deist, C Hivroz, IA Roberts, KM Debatin, A Fisher and JP de Villartay: Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268, 1347-1349 (1995)